New York, United States, March 07, 2023 (GLOBE NEWSWIRE) -- Global Pneumonia Therapeutics Market worth $4.10 billion by 2030
According to a research report published by Spherical Insights & Consulting, the Global Pneumonia Therapeutics Market Size to grow from USD 2.60 billion in 2021 to USD 4.10 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period
Key Insights
- The Pneumonia Therapeutics Market Size was valued at USD 2.60 billion in 2021.
- The Worldwide Market Share is growing at a CAGR of 8.9% from 2022 to 2030
- The Global Pneumonia Therapeutics Market Size is expected to reach USD 4.10 billion by 2030
Get a Free Sample Copy of This Report @ https://www.sphericalinsights.com/request-sample/1539
Pneumonia Therapeutics, a chemical composed of oxygen and hydrogen, is used in a wide range of industrial fields. The chemical is highly suited for usage in the paper and pulp sector, as well as in healthcare, thanks to a number of characteristics it possesses, such as antibacterial and efficient bleaching activities. As an antiseptic, the material is highly sought-after in the healthcare sector and is typically used to scrapes and bruises on the skin to prevent infection. It is commonly used as a mouth rinse due to its ability to lessen mouth soreness, mucous, and other oral illnesses. In order to effectively remove dead skin while preventing infection, the substance primarily releases oxygen, which creates foaming on the cut and bruised skin. The pulp and paper sector is predicted to increase its need for Pneumonia Therapeutics as it is expected to be employed in a wide range of applications. The product's antiseptic properties are also anticipated to result in more demand from the healthcare industry. The dangers that Pneumonia Therapeutics poses to the environment and to human health are expected to limit the market's continued growth.
Treatments for pneumonia are used to both treat and ward off the illness. Pneumonia is an infection that harms people's lungs, especially the alveoli. The alveoli become clogged with pus or liquid. A person with pneumonia will experience fever, chills, a cough, and trouble breathing. Influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) are additional common causes of viral pneumonia. Another frequent cause of bacterial pneumonia is streptococcus pneumoniae (pneumococcus). The commercial operations of several enterprises, including preclinical and clinical testing of microbiome-based treatments and diagnostics, have been severely disrupted by COVID-19 and may still be. It is anticipated that the global pneumonia therapeutics market would grow significantly in the coming years due to the rising frequency of infectious diseases and the growing elderly population with impaired immune systems. Also, from 2023 to 2030, the market is expected to grow more quickly due to increasing research and development efforts by a number of industry players in the production of pharmaceuticals and therapeutic agents. An increase in pneumonia cases is predicted to drive the market for pneumonia therapies over the course of the forecast period.
Browse key industry insights spread across 209 pages with 100 market data tables and figures & charts from the report “Global Pneumonia Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Product (Drugs, Branded, Quinolones, Aminopenicillins, Macrolides, B-lactamase Inhibitors, Cephalosporins, Tetracyclines, Glycopeptides, Generics, Vaccines, Oxygen Therapy), By Distribution Channel (Hospitals, Pharmaceutical Stores, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030“ in detail along with the table of contents https://www.sphericalinsights.com/reports/pneumonia-therapeutics-market
The Vaccines segment is holding the dominance over the forecast period.
Based on the product, the global pneumonia therapeutics market is segmented into Drugs, Branded, Quinolones, Aminopenicillins, Macrolides, B-lactamase Inhibitors, Cephalosporins, Tetracyclines, Glycopeptides, Generics, Vaccines, Oxygen Therapy. Among these, the vaccines segment is holding its dominance over the forecast period. The extraordinary demand is due to the high annual cost of pharmaceutical therapy and the insufficient insurance coverage. Due to the rise in resistant strains and the high mortality and morbidity rates associated with pneumococcal infection, prophylactic medication is now in great demand. Profitable development opportunities are predicted as a result of the 5-year immunisation schedule, high preventive rates of these vaccines, and increased regulatory agency support for vaccination. Oxygen treatment is likely to increase at a moderate rate during the estimated time frame. This is related to the rise of randomised controlled studies for assessing the effectiveness of oxygen therapy in intensive care facilities. Also, the great clinical urgency to create techniques for efficient management, which are crucial in minimising effects, drives the demand for oxygen treatment to treat pneumococcal disease.
The Prevention Vaccines segment is going to dominate the market over the forecast period.
On the basis of distribution channel, the global pneumonia therapeutics market growth is segmented into Hospitals, Pharmaceutical Stores, and Others. Among these, the prevention vaccines segment is going to dominate the market over the forecast period. Many outpatients and inpatients are preferring hospitals because they offer pneumonia treatment from skilled professionals. Also, it is anticipated that hospitals would spend more money developing new techniques to treating pneumonia in the general population during the forecast period. The increased adoption of novel and potent treatments for the ailment is another factor contributing to the rise of the pneumonia therapeutics market.
Pneumonia Therapeutics Market Report Scope: -
| Report Metric | Details |
| Market Size 2030 | USD 2.60 Billion |
| CAGR | 8.9 % (2020-2030) |
| Historical Data | 2019-2020 |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Forecast Units | Value (USD Billion) |
| Segments Covered | By Product, By Distribution Channel, By Region, COVID-19 Impact Analysis. |
| Report Coverage | Drivers, Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Geographies Covered | North America, Europe, Asia-Pacific, Latin America, the Middle East, Africa and Rest of the World |
| Key Companies Profiled/Vendors | AstraZeneca, Lilly, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Merck & Co., Inc., Pfizer Inc., GSK plc, Hikma Pharmaceuticals PLC, Cipla Inc., Lupin |
Buy Now Full Report @ https://www.sphericalinsights.com/checkout/1539 Immediate Delivery Available of this Market Report
North America is dominating the market over the forecast period.
Among all other regions, North America is dominating the market over the forecast period. This emphasises the need for the development of advanced generation medicines and can be attributed to the ageing population as well as the rise in adult and paediatric multidrug resistance. Players in the global market are focusing on new product development and raising their R&D budgets as a result. Moreover, various government initiatives for the identification, management, and prevention of pneumonia have been successful in North America.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Pneumonia Therapeutics market based on the below-mentioned segments:
Pneumonia Therapeutics Market, By Product
- Drugs
- Branded
- Quinolones
- Aminopenicillins
- Macrolides
- B-lactamase Inhibitors
- Cephalosporins
- Tetracyclines
- Glycopeptides
- Generics
- Vaccines
- Oxygen Therapy
Pneumonia Therapeutics Market, By Distribution Channel
- Hospitals
- Pharmaceutical Stores
- Others
List of Key Companies
- AstraZeneca
- Lilly
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- Merck & Co., Inc.
- Pfizer Inc.
- GSK plc
- Hikma Pharmaceuticals PLC
- Cipla Inc.
- Lupin
Get a Discount on Report at https://www.sphericalinsights.com/request-discount/1539
Have a Look at the Related Research Report?
https://www.sphericalinsights.com/reports/japan-veterinary-healthcare-market
Japan Veterinary Healthcare Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Therapeutics, Diagnostics), By End-User Type (Veterinary Services, Veterinary Medical Equipment, Veterinary Hospitals, Veterinary Clinics, Veterinary Laboratory Testing Services, Others), By Animal Type (Livestock Animals (Poultry, Swine, Cattle, Aquatic, Other Livestock Animals), Pet Animals (Dogs, Cats, Horses, Other Pet Animals)) and Japan Veterinary Healthcare Market Insights, Industry Trend, Forecasts to 2030
https://www.sphericalinsights.com/reports/biophotonics-market
Global Biophotonics Market Size, Share, and COVID-19 Impact Analysis, By End-User (Tests and Components, Medical Therapeutics, Medical Diagnostics, and Non- medical Application), By Application (See-Through Imaging, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, and Biosensors), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.
https://www.sphericalinsights.com/reports/alzheimers-disease-diagnostics-and-therapeutics-market
Global Alzheimers Disease Diagnostics and Therapeutics Market Size, Share, and COVID-19 Impact Analysis By Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics), By Diagnostics (Brain Imaging and CSF Test for Alzheimers Disease), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.
https://www.sphericalinsights.com/reports/peptide-synthesis
Global Peptide Synthesis Market Size, Share And Global Trend By Product (Reagents, Equipment & Services), By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) & Hybrid Technology), By Application (Therapeutics, Diagnosis & Research), By End User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization/Contract Research Organization And Academic & Research Institutes); By Region (U.S., Canada, Mexico, Rest Of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest Of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest Of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest Of Middle East & Africa, Brazil, Argentina, Rest Of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends And Forecast, 2021-2030
https://www.sphericalinsights.com/reports/ophthalmic-drugs-market
Global Ophthalmic Drugs Market Size, Share, and COVID-19 Impact Analysis, By Disease (Eye Allergy, Eye Infection, Glaucoma, Retinal disorders, Dry Eye, Other), By Drug Class (Anti-Allergy, Anti-Inflammatory, Antiglaucoma, Anti-VEGF Agents), By Dosage (Eye Solutions, Gels, Capsules, Eye Drops, Ointments), By Administration (Systematic, Topical Local Ocular), By Product (Prescription Drugs, Over-the-Counter-Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030
FAQ’s Of the Market
How big is the Pneumonia Therapeutics market?
Who are the key players in the Pneumonia Therapeutics market?
What are the segments in the Pneumonia Therapeutics market?
What are the major factors driving Pneumonia Therapeutics market?
About the Spherical Insights
Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
Contact Us:
Company Name: Spherical Insights
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
Follow Us: LinkedIn | Facebook | Twitter
